. 2022 Dec 19;95(1):e28393. doi: 10.1002/jmv.28393

Table 3.

Comparison of vital signs and hematological parameters on pre and postintervention between two groups of study

Parameters		Intervention group (n = 125)	Control group (n = 125)	p Value^a
SBP (mmHg)	Before	130 (110−135)	130 (120−139.5)	0.194
	After	125 (120−130)	125 (120–130)	0.332
	p Value ^b	0.043 ^*	0.009 ^*
DBP (mmHg)	Before	80 (73−89)	80 (75−90)	0.533
	After	80 (75−85)	80 (75−85)	0.816
	p Value ^b	0.582	0.223
HR (BPM)	Before	96 (87−103)	95 (87−100)	0.402
	After	83 (78−90)	83 (78−91)	0.427
	p Value ^b	<0.0001 ^*	<0.001 ^*
RR (RPM)	Before	18 (16−19)	17 (16–18)	0.036 ^*
	After	14 (14−15)	15 (14–16)	0.091
	p Value ^b	<0.0001 ^*	<0.0001 ^*
SpO2 (%)	Before	93 (93−96)	92 (89−94)	0.014 ^*
	After	94 (93−96)	94 (93−95)	0.581
	p Value ^b	<0.0001 ^*	<0.0001 ^*
WBC	Before	6.97 (5.08−9.505)	6.86 (5.20−9.35)	0.981
(×10³ cell/mm³)	After	6.2 (5.06−8.050)	7.80 (5.89−10.17)	<0.001 ^*
(×10³ cell/mm³)	p Value ^b	0.070	0.088
Neutrophils	Before	82 (75.05−87.95)	78.2 (71.2–86)	0.011 ^*
(cells/µL)	After	69 (58–78)	67.9 (59−78)	0.851
(cells/µL)	p Value ^b	<0.0001 ^*	<0.0001 ^*
Lymphocyte	Before	6.8 (4.15−10.75)	11 (6.800−15.1)	<0.001 ^*
(×10³ cell/mm³)	After	24.4 (17.0−32.7)	23 (13.85−33.0)	0.205
(×10³ cell/mm³)	p Value ^b	<0.0001 ^*	<0.0001 ^*
Hb (g/dl)	Before	13.5 (11.6−15)	14 (12.5–15.4)	0.078
	After	12.3 (10.35−13.9)	13.3 (11.35−14.6)	0.002 ^*
	p Value ^b	<0.0001 ^*	<0.0001 ^*
Platelet	Before	195 (150.5−251.5)	200 (154.5–240.5)	0.955
(×10³ cell/mm³)	After	260 (205.5–317.5)	251 (195−327.5)	0.764
(×10³ cell/mm³)	p Value ^b	<0.0001 ^*	<0.0001 ^*

Note: Bold values are statistically significant p values.

Abbreviations: DBP, diastolic blood pressure; Hb, hemoglobin; HR, heart rate; RR, respiratory rate; SBP, systolic blood pressure; SpO₂,Saturated pressure of oxygen; WBC, white blood cell.

^{^a}

p Value based on Mann–Whitney u test;

^{^b}

p Value based on Wilcoxon Ranks test;

p < 0.05 considered as significant.